Characterization of cell and biochemical profile of induced sputum and blood in smokers and healthy nonsmokers
Abstract
The aim of this study was to search cell structure of induced sputum (IS), activity of tripsin-like proteinase, elastase and their inhibitors: α1-proteinase inhibitor, α2-macroglobulin and acid-stable inhibitors in the IS and blood serum and of blood neutrophil activity in smokers and healthy nonsmokers.
We examined 67 healthy volunteers aged 19 to 42 yrs. The IS cytograms showed that the absolute amount of neutrophils and the percentage of lym phocytes were significantly higher and the percentage of macrophages was lower in smokers. They also had greater tripsin-like proteinase activity in serum and IS. The average cytochemical coefficient and the percentage of neutrophils with myeloperoxidase granules did not differ reliably in smokers and nonsmokers. There were quite strong positive correlations between smoking, neutrophils, lymphocytes, macrophages in IS and the tripsin-like activity in sputum and serum.
About the Authors
L. I. Volkova
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
E. B. Bukreyeva
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
V. V. Boyarko
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
N. G. Polscha
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
E. A. Dementieva
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
S. V. Nesterovich
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
O. E. Akbasheva
Сибирский государственный медицинский университет
Russian Federation
Russian Federation
References
1. Авдеев С.Н., Анаев Э.Х., Чучалин А.Г. Применение метода индуцированной мокроты для оценки интенсивности воспаления дыхательных путей. Пульмонология 1998; 2: 81-87.
2. Djukanovic R., S terk P.J., Fahy J.V., Hapgreave F.E. Standardised methodology of sputum induction and processing. Eur. Respir. J. 2002; 20: 1-2.
3. Keatings V.M., Colling P.D., Scott D M . Differences in interleukin-8 and tumor necrosis factor in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Respir. Crit. Care Med. 1996; 153: 530-534.
4. Pin I., Gibson P.G., Kolendowiz R. et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-29.
5. О глоблина О.Г., Платонова Jl.В., Пасхина Т.С. Измерение активности трипсина и эластазоподобных протеиназ поли морфно-ядерных лейкоцитов и уровня их кислотостабильных ингибиторов в бронхиальном секрете человека: Метод, рекомендации. М.: М ГУ, 1984.
6. Шутов Е.В. Протеиназы и их ингибиторы у больных хронической почечной недостаточностью: Автореф. дис. ... канд. мед. наук. М.; 1981.
7. Нартикова В.Ф., Пасхина Т.С. Унифицированный метод определения активности а г антитрипсина и а 2-макроглобулина в сыворотке (плазме) крови человека. Вопр. мед. химии 1979; 25: 494-499.
8. Меньшиков В.В. Лабораторные методы исследования в клинике: Справочник. М.: Медицина, 1987.
9. Astaldi G., Verga L. Acta haematol. (Basel) 1957; 17: 129-136.
10. Belda J., Leigh R., Sears M. Induced sputum cell counts in healthy adults. Am. J. Respir. Crit. Care Med. 2000; 161: 475-478.
11. Jayaram L. et al. Induced sputum cell counts: their usefulness in clinical practice. Eur. Respir. J. 2000; 16: 150-158.
12. Hagreave F.H., Leigh R. Induced sputum, eosinophilic bronchi tis and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 160: 553-557.
13. Holz O., Kips J., Magnussen H. Update on sputum methodology. Eur. Respir. J. 2000; 16: 355-359.
14. Lensm ar C., Elmberger G. et al. Leukocyte counts and macrophage phenotypes in induced sputum and bronchoalveolar lavage fluid from normal subjects. Eur. Respir. J. 1998; 12: 595-600.
15. Kips I., Peleman R., Rauwels R. Methods of examining induced sputum: do differences matter? Eur. Respir. J. 1998; 11: 529-533.
16. Доренко В.Л., Нешкова E.A., Чеботарь И.В. и др. Секретирование сериновой связанной с мембраной протеиназы полиморфноядерными лейкоцитами в условиях адгезии на различных типах рецепторзависимых и рецепторнезависимых сорбентов. Вопр. мед. химии 1994; 40: 385-390.
17. Barnes P.I. The role of anticholinergics in chronic obstructive pulmonary disease and chronic asthma. London: National Heart and Lung Institute; 1985.
18. Magnussen H., Hayrgreave F.E. Noninvasive monitoring of airway inflammation. Eur. Respir. J. 2000; 16: 1-2.
19. Saetta M. Airway inflammation in COPD. Am. J. Respir. Crit. Care Med. 1999; 160(5): 17-20.
20. Maestrlli P., Saetta M. Remodeling in response to infection and injury airway inflammation and hypersecretion of mucus in smoking subjects with COPD. Am. J. Respir. Crit. Care Med. 2001; 164: 76-80.
Review
For citations:
Volkova L.I., Bukreyeva E.B., Boyarko V.V., Polscha N.G., Dementieva E.A., Nesterovich S.V., Akbasheva O.E. Characterization of cell and biochemical profile of induced sputum and blood in smokers and healthy nonsmokers. PULMONOLOGIYA. 2004;(2):78-83. (In Russ.)
Views:
180
Email this article 